The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type

被引:65
作者
Foghsgaard, L [1 ]
Jaattela, M [1 ]
机构
[1] DANISH CANC SOC,DIV CANC BIOL,APOPTOSIS LAB,DK-2100 COPENHAGEN,DENMARK
关键词
D O I
10.1128/JVI.71.10.7509-7517.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The development of resistance to host defense mechanisms such as tumor necrosis factor (TNF)- and Fas-mediated apoptosis of transformed or virus-infected cells may be a critical component in the development of disease, To find genes that protect cells from apoptosis, we used an expression cloning strategy and identified BHRF1, an Epstein-Barr virus (EBV) early-lytic-cycle protein with distant homology to Bcl-2, as an anti-apoptosis protein. Expression of BHRF1 in MCF-Fas cells conferred nearly complete resistance against both anti-Fas antibody and TNF-mediated apoptosis, In addition, BHRF1 protected these cells from monocyte-mediated killing but failed to protect them from killing mediated by lymphokine-activated killer cells, The ability of BHRF1 to protect MCF-Fas cells from apoptosis induced by various stimuli was identical to that of Bcl-2 and Bcl-x(L), Moreover, the mechanism of action of BHRF1 resembled that of Bcl-2 and Bcl-x, as it inhibited TNF- and anti-Fas-induced activation of two enzymes participating in the apoptosis pathway, cytosolic phospholipase A(2) and caspase-3/CPP32, but did not interfere with the activation of NF-KB-like transcription factors, A putative function of BHRF1 in EBV-infected epithelial cells may be to protect virus-infected cells from TNF- and/or anti-Fas-induced cell death in order to maximize virus production. Surprisingly, expression of neither BHRF1 nor Bcl-2 in a B-cell line, BJAB, protected the cells from anti-Fas-mediated apoptosis even though they increased the survival of serum-starved cells, Thus, the protective role of BHRF1 against apoptosis resembles that of Bcl-2 in being cell type specific and dependent on the apoptotic stimulus.
引用
收藏
页码:7509 / 7517
页数:9
相关论文
共 59 条
[31]   Apoptosis by death factor [J].
Nagata, S .
CELL, 1997, 88 (03) :355-365
[32]  
NEALE ML, 1988, IMMUNOLOGY, V64, P81
[33]   ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis [J].
Nicholson, DW .
NATURE BIOTECHNOLOGY, 1996, 14 (03) :297-301
[34]   CHECKPOINTS OF DUELING DIMERS FOIL DEATH WISHES [J].
OLTVAI, ZN ;
KORSMEYER, SJ .
CELL, 1994, 79 (02) :189-192
[35]   IDENTIFICATION OF AN EPSTEIN-BARR-VIRUS EARLY GENE ENCODING A 2ND COMPONENT OF THE RESTRICTED EARLY ANTIGEN COMPLEX [J].
PEARSON, GR ;
LUKA, J ;
PETTI, L ;
SAMPLE, J ;
BIRKENBACH, M ;
BRAUN, D ;
KIEFF, E .
VIROLOGY, 1987, 160 (01) :151-161
[36]   NEGATIVE REGULATION OF IMMUNOGLOBULIN-KAPPA LIGHT-CHAIN GENE-TRANSCRIPTION BY A SHORT SEQUENCE HOMOLOGOUS TO THE MURINE B1 REPETITIVE ELEMENT [J].
SAKSELA, K ;
BALTIMORE, D .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (06) :3698-3705
[37]   CPP32 apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis [J].
Schlegel, J ;
Peters, I ;
Orrenius, S ;
Miller, DK ;
Thornberry, NA ;
Yamin, TT ;
Nicholson, DW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :1841-1844
[38]   VIRUSES AND APOPTOSIS [J].
SHEN, YQ ;
SHENK, TE .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1995, 5 (01) :105-111
[39]   NATURAL-KILLER AND LYMPHOKINE-ACTIVATED KILLER-CELLS REQUIRE GRANZYME-B FOR THE RAPID INDUCTION OF APOPTOSIS IN SUSCEPTIBLE TARGET-CELLS [J].
SHRESTA, S ;
MACIVOR, DM ;
HEUSEL, JW ;
RUSSELL, JH ;
LEY, TJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5679-5683
[40]   THE TNF RECEPTOR SUPERFAMILY OF CELLULAR AND VIRAL-PROTEINS - ACTIVATION, COSTIMULATION, AND DEATH [J].
SMITH, CA ;
FARRAH, T ;
GOODWIN, RG .
CELL, 1994, 76 (06) :959-962